The following is a summary of “Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer ...

A 29-year-old Somerset man was arrested and charged after he was caught stealing cooking oil from a pizzeria in Flanders on ...

The conversion of CO2 into e-fuels by light offers a sustainable solution to close the carbon cycle. Researchers at the ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

The environmentally harmful greenhouse gas carbon dioxide, or CO₂ for short, can be converted into valuable chemical products ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

Parkinson's disease affects around 18,000 people in Ireland and can present with over 40 symptoms. While typically diagnosed ...

University of Arizona neuroscientists studying the brains of songbirds have found that aging alters the gene expressions that ...

Pete Stavropoulos; Analyst; Cantor Fitzgerald & Co. Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Operator Instructions) ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB , a company discovering and developing novel ...

Clene (NASDAQ: CLNN) announced new long-term survival data from the HEALEY ALS Platform Trial, showing that treatment with CNM-Au8® 30 mg significant ...